| Euglycemia | Hyperglycemia | ||||
---|---|---|---|---|---|---|
 | Baseline | Empagliflozin | p-value | Baseline | Empagliflozin | p-value |
Blood pressure | Â | Â | Â | Â | Â | Â |
Systolic blood pressure (mmHg) | 111.2 ± 8.9 | 108.5 ± 8.7 | 0.02 | 112.1 ± 9.8 | 110.6 ± 9.8 | 0.2797 |
Diastolic blood pressure (mmHg) | 63.6 ± 8.5 | 63.1 ± 8.1 | 0.6191 | 65.2 ± 8.3 | 63.8 ± 7.3 | 0.2497 |
Pulse (beats per minute) | 74.2 ± 13.1 | 71.8 ± 13.8 | 0.1885 | 72.0 ± 11.0 | 70.8 ± 12.8 | 0.4919 |
Vascular parameters | Â | Â | Â | Â | Â | Â |
Radial augmentation index (%) | -52.0 ± 16.1 | -57.0 ± 16.7 | 0.0001 | -47.9 ± 17.3 | -52.1 ± 17.6 | 0.0190 |
Carotid radial pulse wave velocity (m/s) | 7.3 ± 1.1 | 6.7 ± 0.9 | 0.0001 | 7.9 ± 1.1 | 6.9 ± 0.9 | <0.0001 |
Carotid femoral pulse wave velocity (m/s) | 5.5 ± 0.9 | 5.3 ± 1.0 | 0.1366 | 5.7 ± 1.1 | 5.2 ± 0.9 | 0.0017 |
Heart rate variability | Â | Â | Â | Â | Â | Â |
RMSSD (milliseconds) | 46.3 ± 22.9 | 53.6 ± 32.1 | 0.1050 | 58.0 ± 35.1 | 63.3 ± 37.7 | 0.3004 |
SDNN (milliseconds) | 69.3 ± 24.0 | 73.8 ± 33.2 | 0.3278 | 77.7 ± 32.8 | 83.4 ± 32.2 | 0.2837 |
Biochemistry | Â | Â | Â | Â | Â | Â |
Plasma adrenaline (nmol/L) | 0.13 ± 0.07 | 0.12 ± 0.06 | 0.2946 | 0.13 ± 0.09 | 0.12 ± 0.06 | 0.1097 |
Plasma nordrenaline (nmol/L) | 0.75 ± 0.35 | 0.76 ± 0.36 | 0.8985 | 0.77 ± 0.95 | 0.70 ± 0.35 | 0.6230 |